HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Winnie Deuther-Conrad Selected Research

fluoronorchloroepibatidine

1/2021(+)-[18F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer's disease and healthy controls.
2/2018Exploring the Metabolism of (+)-[18F]Flubatine in Vitro and in Vivo: LC-MS/MS Aided Identification of Radiometabolites in a Clinical PET Study.
12/2016Radiation dosimetry of the α4β2 nicotinic receptor ligand (+)-[18F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Winnie Deuther-Conrad Research Topics

Disease

20Neoplasms (Cancer)
06/2022 - 10/2012
11Alzheimer Disease (Alzheimer's Disease)
01/2022 - 02/2003
8Neurodegenerative Diseases (Neurodegenerative Disease)
04/2022 - 03/2006
4Obesity
04/2022 - 12/2014
4Brain Neoplasms (Brain Tumor)
01/2022 - 03/2018
4Pathologic Processes
05/2021 - 10/2012
3Dementia (Dementias)
01/2022 - 03/2008
3Parkinson Disease (Parkinson's Disease)
01/2021 - 04/2020
3Traumatic Brain Injuries (Traumatic Brain Injury)
01/2014 - 12/2008
2Cognitive Dysfunction
01/2022 - 01/2018
2Disease Progression
01/2022 - 01/2018
2Inflammation (Inflammations)
05/2021 - 02/2003
2Neuroinflammatory Diseases
01/2021 - 01/2016
2Glioblastoma (Glioblastoma Multiforme)
05/2020 - 03/2018
2Substance-Related Disorders (Drug Abuse)
06/2017 - 03/2016
2Weight Loss (Weight Reduction)
01/2017 - 01/2016
2Mental Disorders (Mental Disorder)
01/2017 - 07/2007
2Brain Injuries (Brain Injury)
01/2014 - 12/2008
2Necrosis
10/2003 - 02/2003
2Amyloid Plaque
10/2003 - 02/2003
1Cholangiocarcinoma
06/2022
1Chondrosarcoma
06/2022
1Glioma (Gliomas)
06/2022
1Ischemia
01/2022
1Neoplastic Processes
05/2021
1Hypoxia (Hypoxemia)
05/2021
1Acidosis
04/2020
1Sarcopenia
01/2020
1Muscular Atrophy (Muscle Atrophy)
01/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2018
1Melanoma (Melanoma, Malignant)
03/2018
1Carcinoma (Carcinomatosis)
03/2018
1Morbid Obesity
01/2017
1Hyperthyroidism
12/2016
1Schizophrenia (Dementia Praecox)
03/2016
1Body Weight (Weight, Body)
01/2016
1Tobacco Use Disorder (Nicotine Dependence)
09/2015
1Depressive Disorder (Melancholia)
09/2015

Drug/Important Bio-Agent (IBA)

7Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2021 - 03/2006
5Cholinergic Agents (Cholinergics)IBA
01/2022 - 12/2008
4Adenosine A2B ReceptorIBA
04/2022 - 01/2020
4LigandsIBA
05/2021 - 03/2008
4Proteins (Proteins, Gene)FDA Link
05/2021 - 02/2003
4Pharmaceutical PreparationsIBA
01/2019 - 08/2011
3Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2022 - 01/2014
3Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
02/2021 - 04/2020
3fluoronorchloroepibatidineIBA
01/2021 - 12/2016
2EnzymesIBA
06/2022 - 01/2022
2Purinergic P1 Receptors (Adenosine Receptor)IBA
04/2022 - 01/2022
2Adenosine (Adenocard)FDA LinkGeneric
05/2021 - 01/2020
2Monoamine Oxidase (MAO)IBA
01/2021 - 08/2018
21'- benzyl- 3- (2- fluoroethyl)- 3H- spiro((2)benzofuran- 1,4'- piperidine)IBA
05/2020 - 03/2018
2Cholinesterases (Cholinesterase)IBA
08/2018 - 01/2018
2Biomarkers (Surrogate Marker)IBA
01/2018 - 09/2015
2Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
01/2017 - 01/2016
2Cyclic NucleotidesIBA
01/2017 - 04/2016
2sigma-2 receptorIBA
02/2016 - 10/2012
2Haloperidol (Haldol)FDA LinkGeneric
07/2015 - 08/2014
2Biological ProductsIBA
07/2015 - 10/2012
2Interleukin-6 (Interleukin 6)IBA
10/2003 - 02/2003
2SugarsIBA
10/2003 - 02/2003
2CytokinesIBA
10/2003 - 02/2003
2Advanced Glycation End ProductsIBA
10/2003 - 02/2003
1isocitric acid (isocitrate)IBA
06/2022
1SolutionsIBA
06/2022
1Oxidoreductases (Dehydrogenase)IBA
06/2022
1Histone Deacetylase InhibitorsIBA
03/2022
1Histone Deacetylases (Histone Deacetylase)IBA
03/2022
1SurvivinIBA
01/2022
1Small Interfering RNA (siRNA)IBA
01/2022
13- (1,4- diazabicyclo(3.2.2)nonan- 4- yl)- 6- fluorodibenzo(b,d)thiophene 5,5-dioxideIBA
01/2022
1Cholinergic ReceptorsIBA
01/2022
1CholesterolIBA
05/2021
1Radioisotopes (Radionuclides)IBA
05/2021
1XanthineIBA
05/2021
1GTP-Binding Proteins (G-Protein)IBA
05/2021
1psb-603IBA
05/2021
1Fluorine-18IBA
05/2021
1Selegiline (E250)FDA LinkGeneric
01/2021
1Amyloid (Amyloid Fibrils)IBA
01/2021
1Sigma-1 ReceptorIBA
05/2020
1Monocarboxylic Acid TransportersIBA
04/2020
1Lactic Acid (Lactate)FDA LinkGeneric
04/2020
1RotenoneIBA
04/2020
1Donepezil (Aricept)FDA LinkGeneric
08/2018
1Antineoplastic Agents (Antineoplastics)IBA
03/2018
1NicotineFDA Link
06/2017
1CannabinoidsIBA
05/2017
1Adrenergic Agents (Adrenergic Drugs)IBA
12/2016
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2016
1salicylhydroxamic acid (SHAM)IBA
01/2016
1carfentanil (carfentanyl)IBA
01/2016
1cyclopropanecarboxamideIBA
01/2016
1Opioid Receptors (Opioid Receptor)IBA
01/2016
1LipopolysaccharidesIBA
01/2016
1decaneIBA
07/2015
1Type 2 Cyclic Nucleotide PhosphodiesterasesIBA
05/2015

Therapy/Procedure

14Therapeutics
03/2022 - 12/2014
2Bariatric Surgery
01/2017 - 01/2016
1Drug Therapy (Chemotherapy)
01/2019